Federal Data Hub › HRSA 340B · JSON
340B ID CAH231319-00
ParticipatingCritical Access Hospital
ASPIRUS KEWEENAW HOSPITAL is a Critical Access Hospital enrolled in the federal 340B Drug Pricing Program in LAURIUM, MI. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 18 contract-pharmacy arrangement(s) (5 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.
| Pharmacy | Location | Begin | Terminated | Pharmacy ID |
|---|---|---|---|---|
| ASPIRUS HOUGHTON PHARMACY | HOUGHTON, MI | 2014-07-01 | 2022-02-01 | 91993 |
| ASPIRUS KEWEENAW | LAURIUM, MI | 2011-01-01 | 2022-02-01 | 1899 |
| CYSTIC FIBROSIS SERVICES, LLC | FRISCO, TX | 2019-07-01 | 2023-04-21 | 110069 |
| HEALTHY OPTIONS INC | PORTLAND, OR | 2021-04-01 | 2021-04-14 | 84430 |
| MK STORES INC DBA - SNYDERS DRUG #212 | CALUMET, MI | 2020-01-01 | — | 124333 |
| PRIME THERAPEUTICS SPECIALTY PHARMACY LL | ORLANDO, FL | 2019-07-01 | 2022-10-06 | 39182 |
| SHOPKO PHARMACY 606 | CALUMET, MI | 2013-04-01 | 2019-01-17 | 11849 |
| SHOPKO PHARMACY #2123 | HOUGHTON, MI | 2013-04-01 | 2019-01-17 | 55198 |
| WAL-MART CENTRAL FILL 10-2670 | SPRING, TX | 2014-10-01 | — | 70688 |
| WAL-MART PHARMACY 10-2192 | HOUGHTON, MI | 2012-09-01 | — | 6337 |
| WAL-MART PHARMACY 10-5997 | ORLANDO, FL | 2014-10-01 | — | 39270 |
| WALGREEN CO. | HOUGHTON, MI | 2019-07-01 | — | 100758 |
| WALGREEN CO. | MARQUETTE, MI | 2019-07-01 | 2023-07-10 | 10966 |
| WALGREEN CO. | GREEN BAY, WI | 2019-07-01 | 2023-07-10 | 118660 |
| WALGREENS SPECIALTY PHARMACY, LLC | CANTON, MI | 2019-07-01 | 2023-04-21 | 4981 |
| WALGREENS SPECIALTY PHARMACY, LLC | BEAVERTON, OR | 2019-07-01 | 2021-10-01 | 4982 |
| WALGREENS SPECIALTY PHARMACY, LLC | PITTSBURGH, PA | 2019-07-01 | 2023-04-21 | 4953 |
| WALGREENS SPECIALTY PHARMACY, LLC | FRISCO, TX | 2019-07-01 | 2023-04-21 | 4980 |
Click a Pharmacy ID to see every other 340B entity using that same pharmacy.
The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.
Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.